Lunai Bioworks, Inc. (LNAI)
1.93
-0.01
(-0.52%)
USD |
NASDAQ |
Sep 25, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 19:59
Lunai Bioworks Debt to Equity Ratio : -0.1477 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.1477 |
| December 31, 2025 | -0.2033 |
| September 30, 2025 | -0.2076 |
| June 30, 2025 | -0.4892 |
| March 31, 2025 | 0.0796 |
| December 31, 2024 | 0.0776 |
| September 30, 2024 | 0.039 |
| June 30, 2024 | 0.0287 |
| March 31, 2024 | 0.0638 |
| December 31, 2023 | 0.1696 |
| September 30, 2023 | 0.0984 |
| June 30, 2023 | 0.1203 |
| March 31, 2023 | 0.1064 |
| December 31, 2022 | 0.1048 |
| September 30, 2022 | 0.0993 |
| June 30, 2022 | 0.0966 |
| March 31, 2022 | 0.0454 |
| December 31, 2021 | 0.0442 |
| September 30, 2021 | 0.0438 |
| June 30, 2021 | 0.0422 |
| March 31, 2021 | 0.0469 |
| December 31, 2020 | 0.0499 |
| September 30, 2020 | 0.0462 |
| June 30, 2020 | 0.0456 |
| March 31, 2020 | 0.0445 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0113 |
| September 30, 2019 | 0.0116 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.0046 |
| December 31, 2017 | 0.113 |
| September 30, 2017 | 0.1797 |
| June 30, 2017 | 1.364 |
| March 31, 2017 | -0.274 |
| December 31, 2016 | -0.3214 |
| September 30, 2016 | -0.5465 |
| June 30, 2016 | -0.1614 |
| March 31, 2016 | -1.620 |
| December 31, 2015 | 0.2295 |
| September 30, 2015 | 0.1411 |
| March 31, 2015 | 0.0372 |
| December 31, 2014 | 0.0287 |
| September 30, 2014 | -0.3249 |
| June 30, 2014 | -0.3124 |
| June 30, 2013 | -1.184 |
| March 31, 2013 | -0.4971 |
| December 31, 2012 | -0.3966 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.860M |
| Total Liabilities (Quarterly) | 19.41M |
| Shareholders Equity (Quarterly) | -9.553M |
| Current Ratio | 0.1936 |
| Net Debt Paydown Yield | 6.80% |